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ABSTRACT
Yalamanchili, Hima Bindu. Ph.D., Biomedical Sciences, Ph.D. Program, Wright
State University, 2018. A novel approach for cancer characterization using Latent
Dirichlet Allocation and Disease-Specific Genomic Analysis

Two challenging problems in the clinical study of cancer are the
characterization of cancer subtypes and the classification of individual patients
according to those subtypes. Further, understanding the role of differential gene
expression in the development of and molecular response to cancer is a complex
problem that remains challenging, in part due to the sheer number of genes and
gene products involved. Traditional statistical approaches addressing these
problems are hindered by within-class heterogeneity and challenges inherent in
data integration across high-dimensional data. In addition, many current machine
learning methods do not lend themselves to biological interpretation. We have
developed a novel Latent Dirichlet Allocation (LDA)-based classification
approach to classify unknown samples based on similarity of co-expression
patterns and mitigate these challenges. Integrating this approach with several
recently-developed feature engineering and visualization methods, including
Disease Specific Genomic Analysis (DSGA) and topological data analysis (TDA),
we developed an analysis pipeline that achieves high accuracy compared to
state-of-the-art approaches. We demonstrate the effectiveness of this pipeline on
several data sets including RNA-Seq data from Illumina HiSeq 2000 for breast
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cancer and lung cancer identification, mRNA expression data from Agilent Hu25k
microarray for breast cancer subtype identification and copy-number data from
Affymetrix SNP6.0 for melanoma identification. We also present functional
analysis to identify relevant genes and the associated pathways that could
potentially be involved in differentiating different tumor types.
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I. INTRODUCTION
Cancer is a disease of the genome that arises through genetic
alterations in cells. Cancer is among the leading causes of death worldwide, with
approximately 14 million deaths annually (Ferlay, 2013). Recent projections find
that the most common cancers include breast cancer, lung cancer, colon cancer,
melanoma of the skin, prostate cancer, pancreatic cancer and leukemia.
Breast cancer is one of the most common fatal cancers among women.
More specifically, breast cancer constitutes about 22.9% of all cancers in women
excluding skin cancer. Discovering breast cancer in its early stages and
delivering appropriate therapy promises to reduce the mortality rate; however,
breast cancer is becoming increasingly recognized as not just one disease, but a
group of diseases varied by different molecular subtypes, risk factors, and clinical
behaviors, that lead to different treatment responses (Ng CK et al., 2012). Thus,
accurate grouping of breast cancers into clinically relevant subtypes is important
and can aid in directing patient therapy. There are various factors considered in
classifying breast cancers including origin, stage, grade, histopathology, and
receptor status. Cancer originating from the lobules is called lobular carcinoma,
from the ductal cells is called ductal carcinoma and cancer that spreads from the
origin into other tissues is called invasive carcinoma. Cancer limited to the tissue
of origin is termed as non-invasive carcinoma. Depending on the size and spread
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of the tumor, breast cancer can be further classified into Stages 0, 1, 2, 3 and 4.
Based on the similarity and amount of differentiation of cancerous tissue
compared to healthy tissue, classification can be either Grade 1, Grade 2 or
Grade 3. Histopathology is the direct observation of the cancerous tissue from
biopsy.
Another type of classification is based on receptor status. Currently there
are three main types of receptors observed in breast cancer cells which help in
deciding the course of treatment: estrogen receptor (ER), progesterone receptor
(PR) and human epidermal growth factor receptor 2 (HER2/neu). Breast cancer
cells that have ER, PR or HER2 receptors require corresponding hormones for
growth and are labelled ER+, PR+ and HER2+ respectively. Blocking of these
hormones or receptors with drugs can stop the growth of cancer. For example, in
case of HER2, monoclonal antibodies like trastuzumab are designed to bind to
the protein and make it unavailable for cancer cells (Romond et al., 2005).
Based on these receptors, there are at least five distinct molecular breast
cancer subtypes reported in previous studies (Perou et al., 2000). These include
basal, HER2, luminal A, luminal B, and normal-like. These subtypes have their
own genetic signature and may require different treatment regimens (Fasching
PA et al., 2011, Sotiriou et al., 2003). Luminal A is the most common breast
cancer subtype, accounting for 40% of breast cancers. These tumors tend to be
ER+ and/or PR+ and HER2-. Luminal B constitutes about 10% to 20% of breast
cancers (Perou et al., 2011, Voduc et al., 2010). Like luminal A tumors, most
luminal B tumors are ER+ and/or PR+, but they are distinguished by either
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expression of HER2 or high proliferation rates (Cheang, et al., 2009). Luminal A
and luminal B tumors are associated with more positive short-term prognosis
because the expression of hormone receptors is predictive of a favorable
response to hormonal therapy. About 10% to 20% of breast cancers are basallike and are referred to as triple negative because they are ER-, PR-, and HER2(Carey et al., 2006, Voduc et al., 2010). Basal-like tumors also express
myoepithelial markers (CK5, CK14, CK17 and laminin) and overexpress EGFR.
Women diagnosed with basal-like breast cancer have a poorer short-term
prognosis than those diagnosed with other breast cancer subtypes because
there are no targeted therapies for these tumors. About 10% of breast cancers
produce excessive HER2 (a growth-promoting protein) and do not express
hormone receptors (ER- and PR-; Perou, 2011). About 5-10% of breast cancers
are normal-like and lack ER, PR and HER2. Unlike basal, they lack CK5 and
EGFR and express gene characteristics of adipose tissue. Significance of
normal-like tumors is undefined, and some studies consider these to be an
artifact resulting from high percentage of normal cells in tumor specimen (Parker
et al., 2009, Peddi et al., 2012). The breast cancer taxonomy including the five
molecular subtypes (luminal A, luminal B, basal-like, HER2 and normal-like) is a
working model, and that additional molecular subtypes with distinct molecular
aberrations and clinical behavior will be identified. In fact, recent studies have led
to the identification of c-myc (Nicolau et al., 2011), Claudin-low (Herschkowitz et
al., 2007) and molecular apocrine subtypes (Prat et al., 2010), whose clinical and
biological significance remain to be fully elucidated. Taken together, these
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observations demonstrate that the final molecular taxonomy of breast cancer is
likely to be more complex than initially visualized (Perou et al. 2000). A great deal
of research is being done on breast cancer and its subtypes to identify changes
in molecular function and develop therapeutic targets.
Lung cancer is the second most common cancer in both men and
women (cancer.org). Based on their appearance under a microscope, the two
main types of lung cancer are non-small cell and small cell lung cancer (SCLC).
The non-small cell lung cancer (NSCLC) is the prevailing form of lung cancer and
is responsible for 85% of the total lung cancers in America (American Cancer
Society, 2016). The most common tumors in this category are adenocarcinoma
(about 40%), lung cancer in nonsmokers, and squamous cell carcinoma (about
25-30%), which is a lung cancer that is positively correlated with tobacco
smoking (Anagnostou, et al., 2012). Whereas adenocarcinoma is formed in
glands that secrete mucus or fluids in different parts of the body, squamous cell
occurs in the bronchi within the central region of the chest. The remaining 15% of
lung cancers are SCLC. In the body, this type of cancer spreads relatively
quickly, exhibiting a higher growth rate and shorter multiplying time.
Chemotherapy is a more effective treatment for SCLC. Diagnosis is a critical
challenge in treating lung cancer. Two-thirds of lung cancer patients are
diagnosed at late, metastatic stages (2% survival rate) whereas 49% of patients
diagnosed early will likely survive longer (Leidinger et al., 2010). Current
prognosis for lung cancer patients is poor (<=15%) creating a need for new and
improved therapeutic strategies (Brambilla et al., 2009).
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Skin cancer is the most common of all cancers in the United States.
There are 5.4 million new cases of skin cancer in the U.S. every year (Rogers et
al., 2015). Melanoma and nonmelanoma are the two forms of skin cancer.
Melanoma arises from the malignant transformation of epidermal melanocytes,
pigment-synthesizing cells of the skin. Although melanoma is the rarest form of
skin cancer (2% of skin cancer), it accounts for the majority (75%) of skin cancer
related deaths. Melanocytes can give rise to either benign (i.e., nevi) or
malignant (i.e., melanoma) growths. In most of the cases, dermatopathologists
can accurately distinguish a nevus from melanoma. However, certain ambiguous
histopathological features overlap between nevi and melanoma leading to
diagnostic difficulty. Such uncertainty and ambiguity in melanoma diagnosis often
leads to misdiagnosis, increased medical costs, unnecessary stress, and
negligence of the disease (Corona et al., 1996, Lodha et al., 2008). Some of the
approaches for evaluating melanocytic tumors include Hematoxylin and Eosin
(H&E)

staining,

immunohistochemical

staining,

and

fluorescent

in

situ

hybridization (FISH) assays (Dorvault et al., 2001, Wang, L et al., 2013). Based
on the 5-year survival rate of melanoma, early diagnosis is the most effective
way for long-term survival of melanoma patients.
Accurate cancer diagnosis and classification of tumors types is crucial
for the successful application of specific therapies. Conventional classification
techniques primarily based on morphological and clinical characteristics of the
tumor have been reported to have limitations (Azuaje, 2000). Tumors with similar
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histopathological appearance can be molecularly heterogeneous, differently
responsive to therapy, and thus may require different clinical courses (Azuaje,
2000). To gain better insight into this issue, cancer detection based on genomic
data has been widely explored (Meyerson et al., 2010).
Recent studies demonstrated that DNA microarrays could provide useful
information for cancer classification at the gene expression level, due to their
ability to measure the abundance of messenger ribonucleic acid (mRNA)
transcripts for thousands of genes simultaneously. For example, Alizadeh et al;
(2000) identified two previously unknown groups of large B-cell lymphoma
(DLBCL) using gene expression profiling. Bittner et al; (2000) were able to
identify previously unrecognized subtypes of cutaneous melanoma by gene
expression studies of 31 melanoma biopsies. One study by Sorlie et al; (2001)
found gene expression profiles that could be used as prognostic markers for
overall and relapse-free survival in breast cancer tissue. Ramaswamy et al;
(2003) found 128 genes differentially expressed between primary and metastatic
adenocarcinomas. Roepman et al; (2005) built a gene predictor that could detect
local lymph node metastases in primary head and neck squamous cell
carcinomas. Application of microarrays in these studies helped create a better
understanding of the biology, diagnosis and treatment of cancer.
While microarrays are widely used and have shown great promise over the
years, they do have certain limitations: 1) Microarray design requires a priori
knowledge of the genome or genomic features. This restriction affects array
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effectiveness in cases of incomplete or outdated genome annotations. 2) Crosshybridization can happen between similar sequences. 3) The variety of available
microarray formats, preparative methodologies and analytical approaches may
limit the reproducibility of microarray data between studies. 4) Another obstacle is
the high signal to noise ratios: That is, because of saturation in fluorescence, it is
difficult to differentiate between two very highly expressed transcripts, even with
a significant difference between the two. Also, it’s easy for the expression of lowabundance transcripts to get lost in the noise inherent to microarrays. Other
limiting factors are normalization, interpretation, and the cost. Microarray
experiments must be normalized to account for the noise difference. However,
there is no general agreement on how normalization should be done, and
normalization procedures tend to be different from experiment to experiment
(Draghici, 2001). Another limitation is the overall cost of the experiment. Many
experiments require several arrays with different samples that could potentially
increase the cost of the experiment.
The great depth of sequencing offered by Next-generation sequencing
(NGS) made them available to various applications for which DNA microarrays
had been used, while overcoming many problems associated with the latter. The
term ‘Next-generation sequencing’ applies to several commercially available
platforms. The most commonly used NGS platforms are 454 pyrosequencing
(Roche/454 Life Sciences), ion semiconductor (Ion Torrent sequencing),
sequencing by synthesis (Illumina sequencing), sequencing by ligation (SOLiD
sequencing)

and

nanopore

sequencing.
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NGS-based

approaches

offer

advantages compared to microarrays: 1) Knowledge of genome annotation is
helpful, but not required. It can identify previously uncharacterized mRNA
isoforms and new classes of non-coding RNAs, as opposed to microarrays,
which provide relative quantitation only for probe sequences specifically included
on the chip being used. 2) Genetic material is directly sequenced removing
cross-hybridization issues from the analysis. 3) Because all next-generation
platforms have the same data output (a record of sequences), it is hoped that the
reproducibility of experiments will be much improved over a variety of microarray
platforms. 4) Quantification of signal from sequence-based approaches is based
on counting sequence tags rather than relative measures between samples, thus
eliminating the high signal to noise ratio. On the other hand, some limitations of
NGS technologies are producing short read-lengths that tend to complicate
interpretation of results in some instances and the need for extensive analytic
capability.
Analysis of high-throughput gene expression data is a challenging task,
often complicated by small sample size (typically in the tens) and large number of
gene expression values (high dimensionality, typically in the tens of thousands).
With such a huge dimensionality space, classical statistical or computational
methods are likely to over-fit the data. Selection of relevant genes involved in
different types of cancer (feature selection) is also a challenge. Several machine
learning methods have been applied to this problem because of their ability to
model non-linear relationships and construct interpretable models.
Machine Learning
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Machine Learning is a field of artificial intelligence that uses algorithms to
find patterns in data and make predictions about future events. In machine
learning, observations are generally referred to as instances and the variables
are called features or attributes. Observations, then, are thought of as data points
in a d-dimensional space, where d is the number of features measured
(dimensionality). In practice, machine learning algorithms are employed in two
phases: the training phase during which the algorithm model’s data properties
associated with each class; and the testing phase, during which the algorithm
uses the trained model to predict the class of new data. There are two main
types of machine learning methods: supervised learning and unsupervised
learning. In supervised learning, a labeled set of training data (i.e., target labels)
is used to map the input data to the output. In contrast to supervised learning,
target labels are not present in unsupervised learning and the algorithm tries to
find similarity among groups/clusters within the data. Another type of machine
learning method is semi-supervised learning, which combines both labeled and
unlabeled data to construct an accurate learning model. Usually, this type of
learning is used when there is more unlabeled data than labeled. Depending on
the classification task and the data available, the algorithm required can be a
supervised, unsupervised or semi-supervised model. Some of the most
commonly used algorithms that will be applied in this project are discussed here:
Unsupervised learning
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The k-means algorithm, where k is the number of clusters
(MacQueen,1967), is one of the simplest unsupervised learning algorithms. It
begins by creating k centroids, and iterates between an assign step, where each
sample is assigned to its closest centroid and an update step, where each
centroid is updated based on the mean of all samples assigned to the cluster.
This iteration continues until some stop criterion is met.
Hierarchical clustering is based on distance connectivity. It can be either
agglomerative, which considers each sample as a separate cluster and then
merges the clusters; or divisive, which starts by considering all samples as single
clusters and then divides the cluster into sub-clusters, and so on (Rokach Lior,
2005). The distance between clusters is based on the distance between
individual samples. In ‘single linkage’, the distance between two clusters is the
minimum distance between any sample in the first cluster and any other sample
in the second cluster. In ‘complete linkage’, the distance between two clusters is
the maximum distance and in ‘average linkage’, it is the average distance
between the samples. The arrangement of the clusters produced by hierarchical
clustering can be illustrated with a dendrogram, which is a useful approach to
illustrate the results.
Supervised learning
K-nearest neighbor (k-NN) classification is one of the simplest machine
learning methods. It takes the most frequent class as measured by the weighted
Euclidean distance (or some other distance measure) among the k-closest
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training examples in the feature space. Drawbacks of this model include slow
classification times, high memory usage, and a propensity for overfitting the
training data. In some cases, these can be mitigated by using dimensionality
reduction algorithms. There have been concerns regarding the use of k-nearest
neighbor with cancer data sets, especially when the class distribution is skewed.
That is, this technique tends to assign the new sample, a more frequent class
because they are common among the k nearest neighbors due to their large
number. However, recent considerations have shown that one way to overcome
this problem is to weight the classification, considering the distance from the test
point to each of its k nearest neighbors.
Support Vector machines (Vapnik, 1995) work by classifying instances
based on a linear function of the features. The goal of a support vector machine
is to search for a hyperplane that maximizes the margin between two classes,
where margin is defined as the distance between selected (boundary) data points
of the different classes ("support vectors"). If the data is not linearly-separable,
the support vector machine may employ a kernel to map the data to a higher
dimensionality space in which the classes can then be separated by some
hyperplane. The three most popular kernel methods are: linear, polynomial, and
radial basis functions.
Naive Bayes (NB) Naive Bayes (Hill, 1965; Langley et al., 1992) is a
probabilistic classifier based on bayes theorem. Naive bayes estimates the
probability of an instance belonging to a class given the class probability, which
is the probability of class in a dataset and conditional probability, which is the
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probability of the feature value. It assumes conditional independence among all
variables given the class label. A growing trend is noted the last decade in the
use of supervised learning techniques, namely SVMs and NB towards cancer
prediction and prognosis (Akay 2009, Chuang et al., 2011, Eshlaghy et al.,
2013).
Decision trees use a tree-like branching approach to classify instances
(Quinlan, 1986). Each node in the tree represents a test of some attribute of the
instance, and each branch from that node represents the possible value for that
attribute. The path from the root node, moving down tree branch to the leaf
represents classification rules to classify an instance. An advantage of the
decision tree is that it is very simple to understand and interpret. Several reports
have successfully used decisions trees for gene identification and classification
within cancer datasets (Chen et al., 2014, Elouedi et al., 2014)
Disease-Specific Genomic Analysis (DSGA) is a specialized case of
clustering and class prediction. DSGA can be used in microarrays, DNA, RNA,
and any other high-dimensional genomic or proteomic data and in some
experiments, has outperformed standard clustering methods (Nicolau et al.,
2007). DSGA first models the normal gene expression data and subsequently
extracts the disease-specific component as a deviation from normal (Nicolau et
al., 2007). That is, normal gene expression data is modelled by dimensionality
reduction using an approach like principal component analysis. Next, each
cancer gene expression profile is fit to this normal model and the residual is
defined as the disease-specific component (Figure 1).
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Figure 1 Representation of DSGA
The figure illustrates the decomposition of tumor data vector into the normal and
disease components. Copyright acknowledgement to “Monica Nicolau et al.
Disease-specific genomic analysis: identifying the signature of pathologic biology
Bioinformatics (2007) 23 (8): 957–965
Text Mining
Another important application of machine learning that has received
considerable attention is related to World Wide Web and document retrieval. For
example, when we search on the World Wide Web using a search engine, it is
just looking for words in common: if there is one document about hormonal
regulation and ovarian cancer, and another document about differential gene
expression in breast cancer, they may not appear to have words in common, but
it is important to identify that there are commonalities in those documents: they
are about cancer and gene regulation. Text mining techniques are designed to
reveal such concepts/relationships in textual data that are not visible to the naked
eye. We used this advantage of being able to identify the relationships that aren’t
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evident and apply the same power to infer relationships that can help differentiate
between cancerous and healthy tissues based on topics identification.
Topic modeling is a machine learning approach most commonly employed
in text mining to reveal the underlying thematic structure of documents (Blei,
2002). In topic modeling, a document is described as a mixture of topics, each
with a specific probability distribution over the set of available words. Topic
modeling has shown promise in the fields of text mining and image retrieval,
where it has been successfully implemented to extract information from highdimensionality data (Andrzejewski, 2006; Song, 2013). Given the successful
implementation of topic models in discovering the useful structure of the
documents, topic modeling was also used to analyze data other than document
collections (Chen et al. 2012, Rogers, 2005, Zhao et al. 2014). Its wide
application can be attributed to its interpretability and effectiveness in handling
large datasets. Latent Dirichlet Allocation (LDA) is one of the most popular topic
modeling approaches in text mining among others like Latent Semantic Indexing
(LSI) and Probabilistic Latent Semantic Analysis (PLSA) (Deerwester, 1990;
Hofmann, 2001).
Latent Dirichlet Allocation (LDA) is probably the earliest and most widelyused unsupervised topic model. LDA is a probabilistic model that transforms a
collection of discrete data into a set of latent (hidden) relations in the form of
topics (Blei et al, 2003). Because of its strength for finding underlying relations,
LDA has been broadly applied in various domains like web-spam filtering,
analyzing trends in science publications, and exploring blog conversations.
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In case of text documents, LDA automatically discovers the underlying
topics those documents contain. The input of LDA is typically a simplified “bag-ofwords” representation of a corpus. In this representation, a corpus is reduced to
a multiset of words, maintaining word counts, but disregarding context, order,
and structural features. The algorithm does not know what a word really means,
but it does discover related words due to co-occurrence. The algorithm can be
represented as a graphical model as described in Blei et al. (2003) shown in
Figure 2.
In the given model, rectangles termed as plates represent replicates,
circles represent nodes/variables, and arrow direction shows dependency of the

Figure 2 Graphical representation of LDA
The boxes are “plates” representing replicates. The outer plate represents
documents, while the inner plate represents the repeated choice of topics and
words within a document. Adapted from Blei et al. 2003, Journal of Machine
Learning Research 993-1022
variables. A corpus is defined as a collection of M documents, each with a
sequence of words W. The inner plate represents Z topics and N words within a

15

document. α and β are hyperparameters for the Dirichlet distribution, used for
generating a topic-distribution to draw a topic Z, and a word-distribution to draw a
word W respectively. The model runs through several iterations of assigning
words to topics to improve the model. The resulting output is a word-topic
distribution, a list of probabilities of words in a topic, and a topic-document
distribution, a list of proportions of documents in a topic where it is assumed that
a document consists of one or more topics. Each document is a mixture of topics
summing up to 1.
The output of LDA reflects its ability to cluster the documents with similar
topic-document probability. Nonetheless, LDA is not only a clustering algorithm
but can also interpret the results based on word-topic probability distribution. It
allows data to come from mixture of topics instead of one topic which is critical
for various biological applications. An advantage of LDA is that it can be adapted
to other analysis keeping the analogy between document, topic and word. For
example, much like the words in a document are driven by what that document is
about, we can imagine a document as a collection of topics and the select words
from those topics to fit into the document. Similarly, a snapshot of gene
expression of an individual is driven by biological processes that are topic-like,
and that the mRNAs that are expressed in a given cell or tissue at a specific time
are a stochastic result of the combination of biological states and processes
active in that cell or tissue. That is, topics can be synonymous to processes and
words are synonymous to transcripts.
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Topological Data Analysis (TDA)
Another approach to unsupervised learning is lower-dimensionality
embedding and visualization, and one example to this is Topological Data
Analysis (others are t-SNE, isomap, etc.) with regards to data analysis of high
dimensional data. Although there exist various machine learning methods that
aim to uncover the geometric structure of data including clustering, manifold
learning and nonlinear dimensionality reduction, most of them produce
unstructured scatterplots and distinct, unrelated groups. These methodologies
involve transforming original data in a way that loses some potentially valuable
information and sometimes obscure geometric features, which topological
methods capture. For instance, dimensionality reduction algorithms such as
principal component analysis (PCA) and multidimensional scaling (MDS)
transform the original data, wherein data points well apart in original dimensions
overlap in reduced dimensions eventually.
Topological Data Analysis (TDA) on the other hand leaves data in its
original, high-dimensional space and can find interesting patterns/clusters in
data, and the feature of clusters will be carried out even after running the
algorithm. TDA uses ideas from algebraic topology and aims to uncover relevant,
qualitative and quantitative topological structures underlying complex and
possibly high dimensional data (Carlsson, 2009). The basic motivation behind
TDA is that data has shape and shape has meaning that might help us discover
relationships and patterns in data. The two most popular approaches in TDA are
the Mapper algorithm (Singh et al., 2007) and persistent homology (Edelsbrunner
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et al., 2002). The Mapper algorithm is visualization method that preserves
topological structure to be interpreted by human or machine, whereas persistent
homology provides a framework and efficient algorithms to encode the evolution
of the topology of shape from small to large scale.
TDA has gained tremendous popularity recently due to its generality that
can be applied to any type of data (Nicolau et al., 2011, Severksky et al., 2015).
However, the output from TDA may still needs to be interpreted for better
understanding. As a result, the combination of TDA and machine learning can be
much more powerful and TDA makes machine learning methods much more
effective.
Evaluation Metrics
In comparing machine learning models, prediction accuracy (Equation 4)
is not always the most relevant measure of performance. For example, an
algorithm designed to predict whether a patient has leukemia can achieve a high
overall accuracy simply by always predicting "no". Several metrics have been put
forward in the machine learning community to measure overall model
performance, considering both false negatives and false positives. A few of the
most common metrics are sensitivity (Equation 2), specificity (Equation 3), and
the receiver operator characteristic (ROC) curve. The area under the ROC curve
(AUC) is a good indicator of overall performance and balance.
A confusion matrix (Figure 3), is a good visualization of the performance
of a supervised algorithm. A confusion matrix of size c × c (c = the number of
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classes) represents the rows with actual class and the columns with the
classifiers predicted class. Several of the metrics mentioned above are
calculated from the confusion matrix values.

Figure 3 Confusion Matrix
True positive (TP) is the number of positives correctly identified, true negative
(TN) is the number of negatives correctly identified, false positive (FP) is the
number of negatives incorrectly identified as positive, and false negative (FN) is
the number of positives incorrectly identified as negatives.

Precision = T P/T P + F P

(1)

Sensitivity (Recall) = T P/T P + F N

(2)

Specificity = T N/T N + F

(3)

Accuracy = TP+TN/TP+FP+FN+TN

(4)

F-measure = 2(precision)(recall)/precision + recall

(5)

T P R = T P/T P + F N

(6)

F P R = F P/T N + F P

(7)

The Receiver operating characteristic (ROC) curve plots the tradeoffs
between true positive rate (TPR) (sensitivity/ recall) (Equation 6) and false
positive rate (FPR) (1-specificity) (Equation 7). The best performance is noted by
a curve with a small false positive rate and a large true positive rate. A
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quantitative measure of area under the receiver operating characteristic is called
AUC. The higher the AUC, the better the classifier performance.
Calculation of performance on the same data used to train a machine
learning model can result in a positively biased estimator of true performance. To
determine whether a trained model will generalize well to new data, it is
necessary to evaluate the model on data not used during training. Among the
most commonly-used methods for evaluating the performance of a classifier are:
holdout, random sampling, cross-validation, and bootstrap. In the holdout
method, the data samples are split into two disjoint sets, namely the training and
the test sets. One of the problems associated with the hold-out method is that
splitting reduces the amount of data available for training. This can be mostly
eliminated by using random sampling, in which the holdout method is repeated
several times and chooses different subsets of training and testing instances
randomly. The performance metric is then averaged. Another potential problem
of the holdout method is that the performance metric (such as accuracy) can vary
depending on the distribution of the instances in the training and test sets. Crossvalidation is the process of splitting the dataset into k-equal subsets, where k−1
subsets are used for training while the remaining subset is used for testing. This
is repeated k times so that each sample is used the same number of times for
training and only once for testing. Accuracy is then computed as the average
accuracies across all cycles. Bootstrap approach works by sampling with
replacement from the original data. Some samples will be picked more than one
time and the samples that are never picked are used for testing.
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II. LITERATURE REVIEW
Machine learning in cancer
Many machine learning techniques have been proposed for molecular
classification of cancer and shown to have statistical and clinical relevance: Selforganizing maps were used to analyze acute Leukemia (Golub et al., 1999),
supervised learning approach for predicting outcome in Lymphoma (Shipp et al.,
2001), Brain cancer (Pomeroy et al., 2002), hierarchical clustering for
identification of distinct adenocarcinoma subclasses (Bhattacharjee et al., 2001)
and to analyze colon cancer (Alon et al., 1999), a support vector machine was
applied to classification of multiple primary tumors (Ramaswamy et al., 2001),
breast cancer (Veer et al., 2002), prostate cancer (Singh et al., 2002), and lung
cancer (Wang et al., 2014). Recently, Sharma et al; (2012) proposed a gene
selection algorithm by using Bayes classification approach. It begins with an
empty feature subset and keeps adding features that provides the maximum
information to the current subset. This process continues until no feature can add
information to the current subset. The proposed algorithm is carried out on
several publicly available microarray datasets including lung cancer and breast
cancer data and obtained an average accuracy of 96.3%.
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Machine learning techniques have been increasingly applied to different
classification and clustering problems, not only for disease identification, but also
for survival analysis (Zupan et al., 2000), imaging studies (Lu et al., 2015) and
identification of cancer subtypes. Delen et al; (2005) used artificial neural
networks, decision trees and logistic regression to develop prediction models for
breast cancer survival by analyzing a large dataset, the SEER cancer incidence
database. Computational models such as convolutional neural networks (Ciompi,
2015), regression trees (Lu, 2015), and support vector machines (Demir, 2015)
have demonstrated promising diagnostic performance in the analysis of lung
nodules on CT. However, many automated detection algorithms are insufficient
for achieving high-specificity beyond the order of 73.91% – 87.87% (Demir, 2015,
Orozco, 2015).
Breast cancer
Hierarchical clustering of differentially expressed intrinsic genes between
individual patients first led to the identification of a novel molecular classification
of breast cancer (Perou et al, 2000). Subsequent studies revealed that similar
molecular subtypes of breast cancer could be identified in multiple cohorts of
breast cancer patients and different molecular subtypes were shown to have
distinct clinical outcomes. For example, Parker et al. (2009) has identified a 50gene classifier that has significant prognostic and predictive values on breast
tumors. Recursive feature addition (RFA), which combines supervised learning
and similarity measures, was used to select relevant genes to specify the cancer
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subtypes (Liu, 2009). Reliable identification of significant genes and cancer
classification based on subtypes have both proven challenging (Negrini, 2010).
However, because of the lack of stringent standardization of the methodology
and breast cancer intrinsic subtype definition, different gene signatures
developed by different studies classify a sample in different categories (Mackay,
2011).
Rejani et al. (2009) proposed an algorithm for early detection of tumor
based on mammograms using support vector machines. For each tumor region
extract, morphological features were extracted to categorize the breast tumor
and SVM was used for classification. Zhang et al. (2007) proposed a method for
improving the performance of SVM classifier in breast cancer diagnosis. The
method is to enlarge margin around separating hyperplane by modifying the
kernel functions resulting in a remarkable improvement of error and
computational cost. Recently, Senturk et al. (2014) analyzed the performance of
seven classification models such as Discriminant Analysis, Artificial Neural
Networks, Decision Trees, Logistic Regression, Support Vector Machines, Naïve
Bayes and K-nearest neighbor for the early diagnosis of breast cancer through
RapidMiner tool and showed that Support vector machine outperforms other
algorithms with a classification accuracy of 96%.
Melanoma
With the implementation of clinical algorithms such as the ABCD rule
(Stolz et al., 1994) and the 7-point checklist (Argenziano et al., 1998), diagnosis
accuracy for melanoma has improved compared to the naked eye examination.
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However, these diagnoses are subjective and complex, hence, the accuracy
relies heavily on the experience of dermatologists, which varies widely (75%85%; Argenziano et al., 2003). In the last few years, a large amount of computeraided approaches has been developed for melanoma diagnosis to reduce this
diagnosis sensitivity. For example, a melanoma recognition system by Ganster et
al; (2001) was developed using k-NN classification based on image processing.
A significant amount of work on distinguishing melanoma from nevi has focused
on machine learning from observation of suspicious moles on the skin (Burroni et
al., 2004, Tenenhaus et al., 2010). More recently, Tenenhaus et al; (2010) used
a Kernel Logistic PLS classifier and reported a performance like dermatologists,
with a sensitivity of 95% and a specificity of 60%. Shrestha et al; (2010) claimed
accuracy over 95%. Much less work has been done on classifying melanoma
from nevi based on genetic data. This may be due to the difficulty of diagnosis or
the number of measurements/features involved.
Topic modeling applications in bioinformatics
Since the emergence of topic modeling for analyzing large scale text
corpora, researchers have successfully implemented this approach in biomedical
text mining (Wang et al. 2009; Bisgin et al. 2011). A survival-LDA (surLDA) was
applied to patient-related texts to categorize ovarian cancer. Here, each patient is
considered as a ‘document’, and text from clinical information and treatment
protocols are represented as ‘words’. On the other hand, there have been efforts
to use topic modeling techniques in the field of bioinformatics to perform
unsupervised analysis and obtain insights into high-dimensional omics data.
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Rogers et al; (2005) and Masada et al; (2009) utilized latent process
decomposition (LPD) for discovery of clusters across samples and genes. Chen
et al; (2010) analyzed composition of DNA sequences using LDA. First, DNA
sequences were represented by N-mer frequencies and later, DNA sequences
were considered as documents and N-mers as words. A similar effort by Rosa et
al. (2015) considered genomic sequences as documents, small fragments of a
DNA string of size k as words, and the topics discovered by LDA are assigned
taxonomic labels. Pan et al. (2010) proposed a hierarchical latent Dirichlet
allocation-random forest (LDA-RF) model to predict human protein–protein
interactions using protein sequence data. First LDA was used to project features
into topic space, then the probability of interaction of two proteins was predicted
by a random forest model based on the topic space.
Topic modeling was also applied to image classification. Coelho et al.,
(2010) utilized LDA to identify subcellular localization patterns in fluorescent
images. Here, an image is represented by a mixture of patterns (topics) and the
key points as words. To improve the classification accuracy of differentiating
normal subjects from patients with schizophrenia, Castellani et al; (2010) used
PLSA and extracted a generative score from the learned model, which was used
as input in SVM for the classification. Here, each image from magnetic
resonance imaging (MRI) was a document, the shape of images to be visual
words, and the geometric patterns of the brain surface were visual topics. More
recently in the field of bioinformatics, topic modeling has been used for feature
extraction and clustering from gene expression data (Zhao et al, 2014). While
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these initial results are promising in clustering, there are many domains where
application of LDA as a classification approach is unexplored.
Topological data analysis applications
TDA has been effective in elucidating patterns in high-dimensionality
data in a variety of different fields ranging from shape classification (Chazal et al.,
2017), clustering and histology images for breast cancer analysis (Singh et al.,
2014). Lum et al., (2012) successfully analyzed three data sets using TDA in
three very different industries, genetics, political science, and sport performance.
Topological applications on imaging data have focused mainly on multivariate
random samples, typically from positron emission tomography (PET) and
magnetic resonance imaging (MRI) studies (Gamble and Heo, 2010; Lee et al.,
2011; Chung et al., 2015). A popular approach is to model the data as a graph
based on sites on the brain and join two sites when the distance between them
exceeds a certain threshold. This approach has also been applied to EEG
functional networks in a mouse model of depression (Khalid et al., 2014). A
previously unrecognized subtype of breast cancer was detected in (Monica
Nicolau, 2011) by topology-based data analysis using microarray data. In their
paper, the authors introduced a new technique called Progression Analysis of
Disease (PAD). PAD is a twostep process implemented first by using DiseaseSpecific Genomic Analysis (DSGA) followed by using Mapper. The method first
identifies robust aspects of cluster analysis, then goes deeper to find a multitude
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of biologically meaningful shape characteristics in the data. They identified a
unique subgroup of Estrogen Receptor-positive (ER (+)) breast cancers that
express high levels of c-MYB and low levels of innate inflammatory genes. These
patients exhibit 100% survival and no metastasis. The group has a clear and
distinct, statistically significant molecular signature, that highlights coherent
biology but is invisible to cluster methods and does not fit into the accepted
classification of Luminal A/B, Normal-like subtypes of ER (+) breast cancers.

HYPOTHESIS
Some of the limitations for machine learning applications in cancer
biology include choosing the right technique, given the high dimensionality, poor
gene interpretation and varying class prediction. Most researchers limit their use
to exploratory data techniques such as PCA or linear regression that are often
uninterpretable. On the other hand, techniques such as decision trees,
convolutional neural nets, text mining and ensemble methods are generally
avoided due to unfamiliarity with using and interpreting techniques, fear of
misuse and lack of user-friendly implementations.
Here, we have developed a novel Latent Dirichlet Allocation (LDA)-based
classification approach to mitigate some of the above challenges and
subsequently aids in classification of tumor types and gene interpretation. There
is sufficient analogy between biological process model and textual topic model,
that LDA will effectively be able to identify processes that we can use to
differentiate cancer tissue from healthy tissue. Further, LDA topic-word
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distribution favors gene annotation, thus providing biological interpretation that
could otherwise be a limitation for majority of the algorithms. Integrating this
approach with several recently-developed feature engineering and visualization
methods, including Disease Specific Genomic Analysis (DSGA) and topological
data analysis (TDA), we developed a novel analysis pipeline. DSGA
transformation brings out unique biology, allows for wide variability of normal,
and emphasizes the degree of deviation from healthy tissue (Nicolau et al.,
2007). Since the aim of this project is not only to build efficient classification tools
but also to bring new insights into biology and medicine, a combination of LDA
and DSGA is well suited for this type of analysis.
I therefore hypothesized that, LDA in association with DSGA and
TDA will effectively classify different cancer types, which in turn achieves
high accuracy compared to state-of-the-art approaches and allows
functional analysis to identify relevant genes and the associated pathways
that could potentially be involved in differentiating different tumor types.
Based on these strategies, we developed an effective pipeline for
characterization of different cancer types which include data decomposition using
DSGA followed by topological data analysis for visualization and finally, class
prediction using LDA topological data analysis. To demonstrate the effectiveness
of this approach, I developed the following 3 specific aims.

1. Assess the effectiveness of Latent Dirichlet Allocation (LDA) in classifying
tumor samples and healthy tissue samples using lung cancer and breast
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2. Determine the effectiveness of LDA in classifying different subtypes of
breast cancer and to identify the genes associated with specific subtypes.

3. Assess the effectiveness of LDA in classifying skin cutaneous melanoma
from benign nevi using copy number data to identify known melanoma
related genes.
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III. MATERIALS AND METHODS
Data Collection and Preprocessing
We obtained the mRNA-Seq data of 229 breast invasive carcinoma samples and
98 lung squamous cell carcinoma samples from The Cancer Genome Atlas
(TCGA) data portal (https://portal.gdc.cancer.gov/). We artificially balanced the
data using only the tumor samples with matched normal samples. Out of 229
breast cancer samples, 117 represent primary solid tumor and 112 represent
solid normal tissue. Of the 98 lung cancer samples, half of the data (49)
represent primary solid tumor and the other half (49) represent solid tissue
normal. Both datasets have 60483 variables with an abundance of zero values –
roughly 45% of all values are zero. Genes that have zero expression value in
more than 10% of samples were removed. This stringent threshold was used to
prevent any bias (multiple bins having genes with exclusively zero expression
value) that might arise in the preprocessing step. After filtering, a total of 23424
genes remained in the breast cancer data and 23996 genes remained in the lung
cancer data.
Breast cancer datasets were downloaded from the Nederlands Kanker Instituut
(NKI) data consisting of 295 tumors and the Breast Cancer Normal (BCN) data
consisting of 150 normal breast tissue samples. Missing data were imputed using
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a knn algorithm with k = 10. Data were also transformed from the original log10
values to log2. Data were then collapsed (mean) by UniGene to the mean. The
resulting data set consisted of 18,970 UniGene clusters. Copy number data of 63
skin cancer samples (42 melanoma and 21 benign nevi) were collected. This
data is from an archive of FFPE skin biopsies collected at a national
dermatopathology laboratory (Dermatopathology Laboratory of Central States,
DLCS, Dayton, OH) and processed in the Center for Genomics Research (CGR),
Department of Biochemistry and Molecular Biology at Wright State University.
The Copy Number Inference Pipeline in GenePattern from Broad Institute was
used to convert Affymetrix SNP6 CEL files to generate segmented copy number
calls for each sample. Segmentation of neighboring CNVs into CN-gain
segments and CN-loss segments was performed based on the copy number
values using circular binary segmentation (CBS) with the default parameters in
DNACopy using scripts written in the R programming language.
Ranking and Corpus generation
One of the challenges in using LDA for genetic studies is the nature of the
data. The input of topic modeling is typically a simplified bag-of-words
representation of a corpus. However, gene expression data is numerical in
nature, and thus needs to be transformed into text to provide appropriate input
for the LDA algorithm. The most commonly used transformation method is
scaling the gene expression matrix and interpreting the discrete values as
gene/word occurrences. The higher the expression value, the higher the
frequency of the gene in the bag-of-words (Bicego et al, 2010; Pratanwanich,
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2014). One limitation to using this approach is that genes that have zero
expression value will not be present in the training corpus. Consequently, this
transformation approach is suitable for clustering and feature reduction, but not
for classification because the test data might have genes that are unseen by the
trained model.
Rogers et al (2005) used Latent Process Decomposition (LPD), a derivative
of LDA, to capture the continuous nature of gene expression data. No significant
difference in terms of accuracy has been reported using LPD compared to
classical approaches like pLSA (Bicego et al, 2012). To alleviate these limitations
and broaden the range of applications using LDA, we developed a novel
transformation strategy using gene-ranking method to generate bag-of-words.
The rationale behind this ranking is that relative ordering of gene
expression is generally stable in a healthy human tissue but is largely disturbed
in a diseased tissue. Within each sample, genes will be sorted in ascending order
based on their expression values. Expression values form a distribution that will
be divided into 20 bins. Actual expression values are then replaced with a
quantized value (expression rank) based on its position. Value 1 indicates the
group with the lowest expression level and value 20 indicates the group with the
highest expression level. The combination of each gene with its corresponding
expression rank (separated by a hyphen), generates a bag-of-words for each
sample. For example, if gene BRCA1 was found in quantized bin 3 for a sample,
the bag-of-words associated with that sample would include the word BRCA1-3
to represent the ranked and quantized expression of this gene. It is important to
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note that because of quantization, comparison between gene and word may not
be absolute since one gene might represent many words across the samples. To
extract gene-specific information from the LDA-derived model, it is thus
necessary to develop a technique to reverse this one-to-many mapping to trace
back genes from the corresponding words without deviating from the expression
rank.
To revert/collapse the genes from their corresponding words, expression
rank and probabilities (of all words representing a gene) will be taken and
normalized over the entire probability distribution (Equation 8)
expg=∑j=1 rankgj*probgj /∑j=1 probgj

(8)

where exp g represents the collapsed expression rank of a gene g, j is the total
number of words representing gene g. rankg ∈ (rankg1, rankg2, ...., rank gj) is a
vector of rank extracted from words, and probg

∈ (probg1, probg2, ...., probgj) is

the vector of corresponding probabilities for the words.
Combining the topic-word probabilities in this manner results in a new
topic-gene matrix, in which each topic is associated with a specific rank value for
each gene. The resulting topic profile will facilitate subsequent classification.
Thereby, ranking method will be able to capture the degree of deviation of gene
expression across different samples and still enable gene interpretability of topics
using topic profiles.
Classification
For each dataset, LDA was implemented using an open source Python
library, Gensim (Rehurek, 2008). The LDA algorithm produces two matrices: the
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topic-sample matrix, which expresses the computed probability of topics in a
sample (document), and the topic-word matrix, containing the probability
distribution over all available words for each topic. The LDA-derived matrices will
be utilized to perform analysis as shown in Figure (4).
Topic Analysis
For testing, LDA-derived topic-sample and topic-word matrices from the
trained model are employed. The new topic-gene matrix/ topic profile generated
above, is used for subsequent classification. This novel approach to classification
using LDA-based topic modeling differs from previous methods (Bicego et al.,
2010) where LDA is solely used as a feature extraction method and requires
running LDA on both training and testing data. The approach proposed here
applies the LDA algorithm only to the training data. Once the LDA model is
trained, topic-word probabilities are used to assign topics to test data based on
word occurrence using the maximum likelihood method. Topic assignments are
then used to classify the testing sample.
To classify a test sample based on the trained LDA, we need to determine
topic probability distribution of the test sample. First, the same pre-processing
step described earlier is applied to the test data, resulting in a bag-of-words
based on ranked gene expression for each test sample. Then similarity (MSE)
between testing data and each topic profile was calculated using Equation 9. The
lower the MSE, the more similar is the topic.
G

M SE = ∑ (expg − bing )2

(9)

g=1
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Where expg represents the collapsed expression rank of gene g in a topic profile
and bing represents expression rank of gene g in test sample.
Gaussian normalization was performed to reduce the range of the MSE,
thus avoiding overflow errors in computation, without affecting the variation
between topics and the softmax function (Equation 10) is applied to ensure that
the probability distribution properly sums to 1.0 (Bishop, 2006). The probability
distribution determined from similarity is used for prediction.
Softmax output = kesMSE

,

(10)

∑ esMSE
k=1

Figure 4 Flowchart of the proposed approach
Highlighted boxes represent the sequence of steps involved. Dashed lines divide
the analysis into four groups: Training, Clustering, Classification and gene
interpretation. Bar plots represent the topic distribution of samples
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Clustering
The LDA derived topic-sample matrix represents the degree to which each topic
is expected to affect the word distribution in each sample. This topic-sample
matrix was used for feature extraction/projection in a manner analogous to
principal component analysis. Each column vector of the topic-sample matrix
represents a single sample. There is one value in this vector for each topic,
expressing the degree of association between the topic and the sample. Thus, if
there are, e.g., three topics identified by the LDA algorithm, each column of the
topic-sample matrix can be considered as a three-dimensional representation of
the

original

sample.

Complete-linkage

and

Euclidean-distance-based

Hierarchical Clustering was applied on the topic-sample matrix to cluster the
samples with similar probability distributions.
Cluster purity and number of misclassified samples were calculated using
Equation (11) to evaluate the clustering performance.
k

Purity = 1/N ∑ maxj|ci∩tj|

(11)

i=1

Where N= number of data points, k= number of clusters, c i= a cluster in K, tj=
classification that has the maximum count for cluster ci.
Cluster purity is an external validation metric to determine the quality of
the clustering with respect to true labels in the data. The closer the cluster purity
is to one, the more closely the observed clusters represent the known class
divisions in the data.
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Disease-Specific Genomic Analysis (DSGA)
A Healthy State Model (HSM) was constructed from normal tissue data
using FLAT construction (Botsch et al., 2007), a method to de-sparse the data in
high dimensions by substituting for each normal tissue vector, its fit to a linear
model in the other normal tissue vectors. For this, we use the Wold invariant
(W(K)) (Eastmen and Krzanowski, 1982; Krzanowski and Kline, 1995; Wold,
1978) designed to measure a version of signal to-noise ratio. We take k so that
W(k) spikes up for the value k and construct the top k-dimensional principal
component approximation of the flat normal data matrix.
Linear models are then used to compute the fitted tumor data matrix to the
HSM (normal component Nc.mat) and the residuals (disease component
Dc.mat). Along with tumor data, a leave-one-out procedure gives an estimate of
the deviation of normal tissue data from the model of the healthy state HSM. Two
matrices are formed from the DSGA transformed data: Dc.mat, the disease
component matrix, and L1.mat whose columns consist of leave-one-out
estimates of the deviation from healthy state. We used Dcmat for our analysis.
Mapper
The Mapper algorithm was introduced by Singh, Mémoli and Carlsson as a
geometrical tool to analyze and visualize datasets (G. Singh and Carlsson,1991).
The power of Mapper method in TDA divides the data (high-dimensional dataset)
into overlapping local clusters by a filter function and similarity between data
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points, and then organizes them to create a low-dimensional graphical summary
of the data. The idea behind Mapper is illustrated in Figure 5 and can be
presented as follows:

Filter & Metric

Resolution

Clustering

Connection

Figure 5 Representation of Mapper
Mapper starts with a set of data points and a filter function and produces a
colored graph that captures the shape of the data. This image of the function is
subdivided into overlapping intervals and clustered separately. Each cluster is
represented by a colored node (a bin of points). Pairs of bins that have points in
common are connected by an edge. Copyright acknowledgement to Evaluating
Ayasdi's Topological Data Analysis for Big Data, HKim2015.
The first step is converting raw data into a point cloud data representing a
shape, for example a circle using filter and metric. We color the circle by filter
values and project on a coordinate to reduce complexity via dimensionality
reduction. Filter function summarizes relevant information from noisy original
data. Different filter functions summarize input data in different manners and
multiple filters can be associated to build higher dimensional complex. Some
examples of filter functions are gaussian density, PCA 1&2, mean, variance and
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neighborhood lens 1&2. Some of the metrics are Cosine, Angle, Euclidean,
Correlation and Hamming.
The second step is defining a resolution for the range of partitioning and
overlapping. Now, the point cloud data is covered with overlapping intervals and
therefore it is broken into overlapping bins.
The third step is clustering. We collapse the points in each bin into clusters
using a clustering algorithm. Mapper uses any clustering algorithm from data
mining to create nodes/ clusters. In other words, node is a clustered
representation of group of data samples from the previous step.
Finally, mapper constructs the output of topological network by
referencing redundant data points where each node is represented by a vertex
and an edge is drawn when there is non-empty intersection between clusters. If
node contains no shared data sample, it remains as singleton.
The final output of a mapper consists of multiple nodes and edges. A
node can contain multiple samples and samples can appear in multiple nodes.
The edge contains redundant data samples. Nodes are then colored by the
average value of the filter function defined on the data points inside the node.
Numeric values of these means are translated into colors just as numeric entries
in a data matrix are turned into color to produce heat maps. Color ranges over
red to blue where a red node contains data samples that have higher average
values and a blue node contains lower average values.
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IV. SPECIFIC AIMS

Specific aim 1: Assess the effectiveness of Latent Dirichlet Allocation (LDA) in
classifying tumor samples and healthy tissue samples using lung cancer and
breast

cancer

gene

expression

data

and

identify

known

relevant

features/biological pathways.

Rationale
Understanding the role of differential gene expression in the development
of and molecular response to cancer is a complex problem that remains
challenging, in part due to the sheer number of genes, gene products, and
metabolites involved. While, datasets involving a few variables are easily
analyzed through simple visualizations and classification methods, large and
complex data sets, which are high-dimensional gene expression data, for
example, are difficult to analyze through conventional means. Such analysis of
high-dimensional data is best accomplished through use of techniques which
mitigate overfitting and develop a high-level understanding of the associated
genes. In this aim, we develop a novel approach to classification of cancer and
normal samples using LDA-based topic modeling and explore the effectiveness
of the method in distinguishing gene expression patterns in cancer tissues

40

from those in normal tissue. For each dataset, LDA was implemented using an
open-source Python library to produce topic profiles for the training data using
the protocol and parameters shown in Figure (4).
Method
To determine an effective method for converting gene expression data into
text and vice-versa, we compared our gene expression transformation (generanking) which is described in detail in Material and Methods with other bag-ofwords transformation methods from the literature.
For

comparison,

we

explored repetition approach

and

previously

implemented median-value approach (Zhao et al. 2014). The median-value
approach is the most commonly used transformation method that transforms
expression values into 0 (lower than median) or 1 (higher than median)
respectively. Within each sample, only the gene that has transformed value 1 is
treated as a word and occurs once in the bag-of-words. Whereas, for the
repetition approach, the gene expression matrix is scaled to discrete values and
those values are then interpreted as gene/word occurrences. To scale, gene
expression values will be sorted in ascending order and divided into 20 bins.
Each gene is treated as a word, and its occurrence is repeated based on which
bin it has been assigned. For instance, if gene BRCA1 was found in quantized
bin 3 for a sample, the word ‘BRCA1’ would be repeated three times in that bagof-words.
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To determine the ideal number of topics and iterations for classification of
gene expression data from lung cancer and breast cancer datasets, parameter
search was performed by running the LDA algorithm on breast cancer gene
expression data with fixed number of topics (2, 3, 5, 10, 20 and 30,), fixed
number of passes (1, 2, 5, 10, 20, 50 and 100,) and fixed number of bins (5, 10,
20, 30 and 40). Optimum parameters were inferred using the classification
approach

described

in

Materials

and

Methods

considering

both

the

computational time and performance.
The performance of our classification approach was compared with
popular supervised methods including SVM, Naive Bayes and Random Forest
classifiers using 10-fold cross validation. Traditional metrics for comparison like
accuracy, precision, recall and F-measure were applied. Similarly, the clustering
result from LDA was compared with other conventional clustering and projection
methods including hierarchical clustering and principal component analysis
(PCA). Hierarchical clustering was directly applied to the raw expression values
for breast cancer (23424 genes) and lung cancer (23996 genes). PCA was first
used to transform the original data into components that retain 90% of the
variance. Hierarchical clustering was then applied on the transformed data. For
both datasets, cluster purity and number of misclassified samples were
calculated using Equation (8) to evaluate the clustering performance.
In addition to diagnostic application, a key objective for feature selection
and classification of expression data in cancer tissues is the identification of
differential expression patterns that may help to understand the etiology of and/or
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molecular responses to specific cancers. Here, we utilized topic profiles from the
two data sets to perform pathway analysis and disease annotation of differentially
expressed genes within each topic. A list of differentially expressed genes
(DEGs) is extracted by computing the difference in expression rank of each topic
with a baseline. For the experiments shown here, topic 3 was chosen as the
baseline in both breast cancer and lung cancer datasets, since it shows the
highest probability in normal samples (Figures 8 and 9). Differentially expressed
genes were then identified from all other topics (1 and 2 in this case). A threshold
rank-difference of 5 was used to extract the significant genes and limit the
number of genes for further analysis. Thus, the extracted genes have at least 5
ranking changes between normal and tumor that could potentially represent
significant dysregulation in our analysis.
Further, we examined the pathway enrichment of the differentially
expressed

genes

using

DAVID

Bioinformatics

Resources

6.8

(https://david.ncifcrf.gov/home.jsp) (Dennis et al. 2003) to explore the KEGG
pathway database. Figures 10 and 11 show the number of genes and statistically
enriched pathways in the topics for breast cancer and lung cancer, respectively.
The relevance of the identified differentially expressed genes was validated using
the DAVID bioinformatics suite (Dennis et al. 2003) and the NIH genetic
association database (GAD) (Becker et al. 2004). The differentially expressed
genes were extracted by comparing the expression profile for normal and tumor
samples, which were generated using the procedure described below. For each
gene, its expression rank (expg) in topic profile matrix (~24000x3) was multiplied
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with respective topic probability distribution of normal group (3x1) and tumor
group (3x1). This would generate two expression profiles: one for normal
samples (~24000 x 1) and one for tumor samples (~24000 x 1). The difference in
expression rank between these two profiles was computed. Using the threshold
of 5, a list of differentially expressed genes was extracted both for breast cancer
and lung cancer and annotated using DAVID Bioinformatics Resources 6.8 in
terms of GAD disease.
Results
Three different sets of bag-of-words were generated using the three
transformation approaches and were used as input for LDA algorithms, using
parameters determined as described below. The topic probability distributions for
both classes generated by these three approaches are shown in Figure 6. The
repetition approach yielded highly similar topic probability distributions for normal
and cancer tissues. Both the median and ranking approaches effectively
generated distinctive topic probability distributions for each class.

Figure 6 Data transformation approaches
Topic probability distribution of breast carcinoma samples for (a) repetition
approach, (b) median approach and (c) ranking approach. Bar plots represent
topic-sample probability for the 3 topics identified by LDA.
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As shown in Figure 7 (c), 1, 2 and 10 passes achieved the highest F-measure
in the classification task. As shown in Figure 7 (b), utilizing five topics achieved
the highest F-measure (0.978), while limiting the number of topics to three
achieved a comparable performance (0.977). The performance of the algorithm
is robust relative to bin size (5, 10, 20, 30, 40 bins).

Figure 7 Parameter Selection.
Comparison of F-measure, accuracy, sensitivity, and specificity with varying
number of a) bins, b) topics and c) passes

Table 1 Classification results of our proposed approach and three
supervised algorithms: SVM, Naive Bayes, and Random Forest
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Figure 8 Topic probability distribution and hierarchical clustering for breast
cancer data
a) Topic probability distribution and b) Hierarchical clustering of samples using
derived topic probability for breast carcinoma. Bar plots represent average topicsample probability for the 3 topics. Heat map shows the clustering of samples
into two classes.

Figure 9 Topic probability distribution and hierarchical clustering for lung
cancer data
a) Topic probability distribution and b) Hierarchical clustering of samples using
derived topic probability for lung cancer. Bar plots represent average topicsample probability for the 3 topics. Heat map shows the clustering of samples
into two classes.
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A very clear separation in topics between the two classes was observed for
both breast cancer and lung cancer data (Figures 8, 9). As shown in table 1, LDA
achieves a competitive performance comparable to other algorithms. Table 2
shows the clustering results of the three methods where the number of clusters
(K) is fixed at 2, 3, and 4 clusters. Overall, LDA clusters align more closely to
known cancer/healthy tissue labels than those obtained by PCA and Hierarchical
Clustering.
Table 2 Clustering results of LDA-derived topic probabilities,
PCA reduced features, and Hierarchical Clustering

Table 3 shows the top 5 highly related diseases which are ranked
ascendingly according to their p-value. As expected, for the gene list extracted
from breast cancer data corpus, ‘breast cancer’ is the disease with highest
enrichment (lowest p-value) and for lung cancer data corpus, it is ‘smoking
cessation’.
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Discussion
While both ranking approach and median approach generated distinctive
topics between the two classes, we chose ranking approach for further analysis
because of the following reasons. One drawback to median approach is that it
requires test samples be transformed along with training samples, which affect
the generation of the bag-of-words to train the LDA algorithm. In other words, the
whole preprocessing step and LDA algorithm must be performed every time a
new test sample is given. Furthermore, preprocessing using the median may risk
having a batch effect, handling both test data and training data separately which
would require another normalization before transformation. The ranking
approach, on the other hand, does not suffer from such an effect and does not
require normalization (Wang et al.)
We chose 10 passes, as it performed better clustering and did not incur
much increase in computational time (not shown). Performance gains with further
increases in the number of topics were limited, and performance begins to
degrade with more than 10 topics. Most importantly, the computational time for
training LDA on gene expression data increases linearly with the number of
topics. Therefore, we selected 10 passes and 3 topics as the most effective
combination for training LDA on our gene expression data. The number of bins
represents the relative ranking of expression level instead of absolute ranking
and hence the observed phenomenon (Figure 7 (a)). We chose 20 bins as a
representative of the performed experiments. While this selection strategy could
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Figure 10 Functional annotation of dysregulated genes in breast cancer.
Venn diagram of differentially expressed genes in Topic 1, in Topic 2 for breast
Cancer. Tables represent the affected pathways for each subset of genes, and
their adjusted p-value. The lower the adjusted p-value, the higher the significance
of the pathway.

T1DEG

T2DEG

Figure 11 Functional annotation of dysregulated genes in lung cancer.
Venn diagram of differentially expressed genes in Topic 1, in Topic 2 for Lung
Cancer. Tables represent the affected pathways for each subset of genes, and
their adjusted p-value. The lower the adjusted p-value, the higher the significance
of the pathway.
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Table 3 Top 5 related diseases from breast cancer and lung
cancer disease annotation

be effective for most gene expression datasets, it may not be suitable for variant
analysis because of the nature of the data where gene expression data presents
a dynamic range.
One advantage of LDA-based clustering for gene expression data may be
its mutually non-exclusive assumption. Most non-fuzzy clustering approaches
have a mutually exclusive/independence assumption that a sample/gene is
restricted to only one cluster. This assumption might not be logical for gene
expression data largely when a sample/gene share characteristic with more than
one cluster (that is one gene can be involved in different pathways/ biological
process). Thus, using LDA for clustering of genomic data would reflect the
complex interplay between genes and pathways and improve quality of the
results.
Gene interpretation using our approach derives significant pathways in both
breast cancer and lung cancer data. The interpretation of differentially expressed
genes depends on sample topic probability between classes. In breast cancer
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data, using the same threshold, more differentially expressed genes are
extracted from Topic 1 compared to Topic 2. This is since Topic 2 predominantly
contains normal sample (Figure 7(a)). Thus, most annotated pathways from
Topic 1 are significantly related to cancer such as PPAR signaling pathway, p53
signaling pathway and AMPK signaling pathway. However, in lung cancer data,
Topic 3 is the only normal topic whereas both Topic 1 and Topic 2 are cancerrelated topics (Figure 8(a)). Thus, there is a huge overlap of differentially
expressed genes between these two topics. Some of the significant pathways
identified from this overlap are p53 signaling pathway, PI3K-Akt signaling
pathway, and Ras signaling pathway.

Specific Aim 2 Determine the effectiveness of LDA to classify different subtypes
of breast cancer and to identify the appropriate genes associated with specific
subtype.

Rationale
Breast cancer is a heterogeneous complex of diseases, a spectrum of many
subtypes with distinct biological features that lead to differences in response to
various treatment modalities and clinical outcomes. It is therefore necessary to
devise a clinically meaningful classification of the disease specific subtypes to
ensure the best possible patient response to therapy. The challenge is to extract
a minimal optimal set of genes with good prognostic properties from a large bulk
of genes making a moderate contribution to classification. In recent years,
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various machine learning methods were applied to extract a subset of genes
allowing for robust classification of subtypes, including support vector machines
(Shieh et al., 2004) and random forests (Guan et al., 2012). Different gene sets
and methods for the identification of the breast cancer subtypes have been
published, outcome of these different methods/gene lists only show a modest
agreement and may assign the same patient to different intrinsic subtypes
(Mackay et al., 2010, Pineda et al., 2015). It has been suggested, however, that
technical limitations such as data normalization and platform annotation may
have reduced the accuracy in subtype predictions (Perou et al., 2010, Ellis et al.,
2012).
In this aim, the focus is on identifying a classification approach that can
reliably predict each of the breast cancer subtypes using gene expression
information. In this context, we develop a novel classification framework using
LDA with a feature selection strategy using DSGA, and we apply it to the
classification of breast cancer subtypes. Hoping that the shape of the point cloud
given by columns of patients with rows of genomic variables would give some
insight on how the types of breast cancers should be grouped, topological based
analysis was also used on the same data.
Method
To compare classification accuracy of LDA-based classifier using breast
cancer gene expression data corresponding to tumor subtypes and with other
machine learning approaches, we applied the classification strategy defined in
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the Materials and Methods to breast cancer gene expression data. Classification
accuracy and F-measure were measured and compared with support vector
machine and Naive Bayes.

W(K)

Dimension of PC space = K

Figure 12 The wold invariant plot for Breast cancer subtype data
Graph is plotted as a function of the dimension reduction K

We further applied feature engineering using DSGA where data from both
tumors and normal tissue were combined, and the Healthy State Model (HSM)
was constructed from normal tissue data using FLAT construction and principal
component analysis. Figure 12 plots W(k) vs. the dimension k and shows a jump
at k = 7, indicating that signal-to-noise ratio is higher at dimension 7, thereby
justifying PCA dimension reduction of the FLAT normal data to 7-dimensional
HSM. Based on HSM, each tumor tissue is decomposed as the sum of two
components: (i) the normal component, its linear model fit to the HSM; (ii) the
disease component, vector of residuals, assessing the extent to which each
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tumor deviates from the normal state. The disease component was used for the
identification of the molecular subtypes yielding 270 unique genes.
Further, LDA was applied on the DSGA transformed data and
classification accuracy and topic distribution were recorded. Additionally, we
applied TDA to the raw data and DSGA-transformed data matrix to visualize the
distribution of data. Mapper filter functions were calculated for the following
parameters: metric = Euclidean (L2), filter = Neighborhood lens 1 & 2, resolution
= 30 and gain = 2.50. It should be noted that multiple outputs can be constructed
by applying all possible combination of metrics and filters. To decrease
information redundancy, we based our selection on the domain knowledge of
gene expression profiling. In this domain, relative expression values among the
genes or probes are valuable to conserve meaningful information more than
absolute gene expression levels. Thus, we selected a metric that can measure
the distance of numerical data points and some of the relevant metrics are
Cosine, Angle, Correlation or Euclidean. Euclidean metric was chosen because it
is least computationally expensive and will be a good starting point for the current
research. Similarly, neighborhood lens 1&2 can be categorized as a projection
filter to magnify distance between the groups. It generates a two-dimensional
embedding of the k-nearest neighbor graph by connecting point to its nearest
neighbors.
To identify the ability of LDA in finding known biological pathways that are
functionally related to breast cancer, we utilized topic profiles from the subtype
data to perform pathway analysis and disease annotation of differentially
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expressed genes within each topic. A list of differentially expressed genes
(DEGs) is extracted by computing the difference in expression rank of each topic
with a baseline. Differentially expressed genes were then identified from all other
topics. A threshold rank-difference of 5 was used to extract the significant genes
and limit the number of genes for further analysis. Thus, the extracted genes
have at least 5 ranking changes between the different subtypes that could
potentially represent significant dysregulation in our analysis. We used DAVID
and GAD to identify differentially expressed genes that associate with specific
subtypes of breast cancer.

Figure 13 Topic probability distribution of breast cancer gene expression
data into subtypes.
Bar plots represent average topic-sample probability of the 5 topics for 5
different subtypes: Basal, HER2, Luminal A, Luminal B and Normal-like
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Figure 14 Topic probability distribution of breast cancer gene expression
samples into subtypes after DSGA transformation.
Bar plots represent average topic-sample probability of the 8 topics for 5
different subtypes: Basal, HER2, Luminal A, Luminal B and Normal-like.

Figure 15 Mapper output for Breast cancer gene expression data before
DSGA (ER+/-).
The output displays ER+ samples (red bins). Each bin is colored by the mean of
the filter map on the points. Blue bins contain tumors whose total deviation from
HSM is small (normal and Normal-like tumors). Red bins contain tumors whose
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deviation from HSM is large. White bins indicate the rest of the samples. Several
bins (singletons) are disconnected from the main graph.

Figure 16 Mapper output for Breast cancer gene expression data after
DSGA (ER+/-).
The output displays ER+ (red bins). Each bin is colored by the mean of the filter
map on the points. Blue bins contain tumors whose total deviation from HSM is
small (normal and Normal-like tumors). Red bins contain tumors whose deviation
from HSM is large. White bins indicate the rest of the samples. Several bins
(singletons) are disconnected from the main graph.
Results
Figure (13) shows the LDA topic distribution of 295 samples and 18,970
genes for all 5 breast cancer subtypes. LDA on raw data however did not result
in good topic separation and accuracy. In this case, we considered doing a
feature reduction (DSGA) that was proven to improve the performance of the
model. DSGA transformation produced a data matrix of 295 samples and 260
genes. Figure (14) shows the LDA topic distribution on the DSGA transformed
data. The performance of our classification approach was compared with popular
supervised methods including SVM, Naive Bayes and Random Forest classifiers
using 10-fold cross validation. Traditional metrics for comparison like accuracy,
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precision, recall and F-measure were applied. Table 4 presents classification
accuracy of our model compared to other classifiers. As revealed by the p-values
of the t-test, the proposed model competes on-par with SVM and Random Forest
in classifying ER, Basal and Lum B and outperforms in classifying all classes,
HER2, Normal-like and Lum B.

Figure 17 Mapper output for Breast cancer gene expression data after
DSGA (basal).
The output displays basal subtype (red bins). Each bin is colored by the mean of
the filter map on the points. Blue bins contain tumors whose total deviation from
HSM is small (normal and Normal-like tumors). Red bins contain tumors whose
deviation from HSM is large. White bins indicate the rest of the samples. Several
bins (singletons) are disconnected from the main graph.
Figures 15 and 16 shows the outputs of mapper before and after DSGA
transformation with red nodes denoting ER+ bins. Each node is a bin of tumors,
and its color encodes the value of the filter function averaged across all the data
points in the bin, with blue denoting a low value and red encoding a large value.
Thus, bins that are blue contain tumors whose expression is close to normal,
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whereas bins that are red contain tumors that generally have large deviation from
normal along multiple genes, in both the positive and the negative direction.

Figure 18 Mapper output for Breast cancer gene expression data after
DSGA (normal-like)
The output displays normal-like. Each bin is colored by the mean of the filter map
on the points. Blue bins contain tumors whose total deviation from HSM is small
(normal and Normal-like tumors). Red bins contain tumors whose deviation from
HSM is large. White bins indicate the rest of the samples. Several bins
(singletons) are disconnected from the main graph.
There are several groups of tumors that stand out. Basal tumors occupy
most of the bins in the tumor sequence denoted as ER− sequence (Figure 17).
They are immediately visible and stand out with large value (red) in the filter
function: overall deviation from normal. Normal-like tissue samples (Figure 18) all
fall in the same bin together with 3 additional ER+ tumors. These are colored
blue and show minimal overall deviation from normal according to the filter
function. Luminal A group (Figure 19) occupies most of the bins in ER+ sequence
owing to the well-understood characteristic that all Luminal A subtype are ER+.

59

Figure 19 Mapper output for Breast cancer gene expression data after
DSGA (Luminal A/B)
The output displays Luminal A/B subtype. Each bin is colored by the mean of the
filter map on the points. Red bins indicate Luminal A tumors and green bins are
Luminal B. White bins indicate the rest of the samples. Several bins (singletons)
are disconnected from the main graph.

Figure 20 Mapper output for Breast cancer gene expression data after
DSGA (HER2+)
The output displays HER2 subtype (red bins). Each bin is colored by the mean of
the filter map on the points. White bins indicate the rest of the samples. Several
bins (singletons) are disconnected from the main graph.
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An additional long tumor sequence on the graph, HER2 showing large
deviation from normal is visible between ER+ and ER- sequence, as defined by
the filter (Figure 20). This group also consists of ER+ tumors supporting the
observation that nearly half of HER2-positive is ER+ but with lower expression
levels of ER (Creighton et al., 2012). Another work from Perou et al., 2012 stated
that luminal B might represent the ER+/HER+ form of breast cancer; however,
HER2 gene does not show high levels in luminal B. As expected and in
agreement with the above statement, a small subset of HER2 tumors in the
above sequence are assigned to luminal B (Figure 20). LDA-DSGA classification
in agreement with mapper results also produced distinct topic distribution of
breast cancer subtypes (Figure 14).

Table 4 Classification results of DSGA transformed breast cancer
gene expression data using LDA, SVM, and Random Forest.
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We extracted unique genes after DSGA transformation, only differentially
expressed genes within each topic were extracted between the subtypes. A
threshold rank difference of 7 was used to extract the significant genes and
pathway analysis results were observed.
We found 120 genes in common among the subtypes. Specific genes for
each subtype are 16 DEG’s for luminal A, 24 for luminal B, 33 for HER2, 58 for
basal and 19 for normal-like. Furthermore, we detected 23 pathways in common
among the subtypes. We detected pathways specific for each subtype in this
proportion: 10 for luminal A, 5 for luminal B, 6 for HER2, 8 for basal and 3 for
normal-like. Table 5 represents the pathways associated with specific subtypes.
10 specific pathways were identified in Luminal A, some among them are
prothrombin pathway and ethanol oxidation. Prothrombin Pathway plays an
essential role in coagulation, a crucial step for metastasis in cancer (Lima et al.,
2013). The pathway of ethanol oxidation contains several genes belonging to the
family of ALDH and that, despite their known role in ethanol detoxification, are
also considered biomarkers of cancer stem cells (Marcato et al, 2011).
We identified 5 specific pathways in luminal B including cell cycle pathway
and cell junction pathway. Cell junctions are necessary for cell-cell adhesion
machinery related to the differentiation and normal growth of the tissue (Alberts
et al., 2002). The progression of cancer represents a modification of normal
tissue homeostasis and an alteration in cell-cell interaction. In addition, Bendas
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et al. 2012 reported that cancer metastasis spreads through the circulatory
system caused by cell adhesion.

Table 5 Functional annotation of differentially expressed genes in breast
cancer subtypes

We identified 8 specific pathways in basal-like including amino acid
synthesis and metabolism of amino acids. It has been shown that deregulated
amino acid metabolism has a function in immune tolerance in cancer (Nagarajan
et al., 2016). 6 specific pathways were identified in HER2 including axon
guidance. Axon guidance pathway includes four families of secreted or
membrane bound factors (i.e., netrin 1, semaphorin, ephrins, and Slit, along with
their receptors), which have recently studied as central agents in tumor
progression.

Discussion
Separation of topics between subtypes using LDA alone was not successful.
This is likely because of overlapping among different breast cancer subtypes
considering some special types of breast cancers: for example, some basal-like
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breast cancers (molecular classification) will not show the expected triplenegative (ER, PR and HER2 negative from immunohistochemistry) and some
HER2 positive tumors are assigned to lum-B. Furthermore, because of the large
number of features used by microarray data sets, there is redundancy of
information. However, feature reduction using DSGA significantly improved the
topic separation between subtypes.
Comparison of the LDA clustering results before and after DSGA
transformation, the Normal-like tumor group (topic 3) is often observed through
both types of analysis. However, the other groups, HER2, basal and luminal
tumor groups were scattered across several topics, as seen in Figure (13). Thus,
unlike DSGA-LDA analysis, cluster analysis solely based on LDA was unable to
identify subtypes of breast cancer. This shows that the appearance of the tumor
subtypes was due to the way data were transformed via DSGA to identify subtle
shape characteristics of the data set. Topic distribution of raw data scattered the
tumors in the ER+ tumor progression and even the very tight basal tumor group.
Thus, a combination of LDA and DSGA is well suited for this type of analysis.
Additionally, DSGA followed by Mapper analysis revealed the topological
connections among samples as a function of the gene-expression data and it
was found that the five molecular subtypes summarize the continuous
progression from samples closer (in the ER+ and luminal A subtypes) to samples
distant (in the Basal and HER2 subtypes) to the normal state. It is likely that the
adoption of the proposed analysis based on LDA-DSGA may help to overcome
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some of the limitations of the previous approaches and prove to be effective in
informing the selection of genes. Furthermore, it does not ignore the precise
identification of morphologically identifiable ‘special’ types of breast cancer,
whose clinical outcome may be strikingly different from that of the other members
of the same class and justifies a different therapeutic option.
The inherent heterogeneity in human breast cancer presents an enormous
challenge for predicting significant pathways and for understanding mechanism
of the disease. This could explain the overlap we observe in the associated
genes and pathways between the subtypes. Nonetheless, our classification
scheme was able to identify some interesting patterns in the gene regulation
between the subtypes. Although these results are important in differentiating the
molecular subtypes of breast cancer, it is critical to validate these further for
clinical applications. Developing a pathway/gene signature based on the
presented results as the basis for tumor classification would be the immediate
step along these lines.

Specific Aim 3 Assess the effectiveness of LDA in classifying skin
cutaneous melanoma from benign nevi using copy number data and to
identify known melanoma related genes.
Rationale
Due to the high skin cancer incidence and mortality rates, early diagnosis of
melanoma has become an extremely important issue. Here, we present a new
approach to the classification of melanocytic lesions. Most of the research done
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so far in this area has concentrated on creating new methods to distinguish
benign from malignant skin lesions. In our research we go one step further and
differentiate melanocytic lesions like melanocytic nevi, and malignant melanoma.
Some tumors have ambiguous histopathological features that overlap
between melanocytic nevi and melanoma. Therefore, the pathology of
melanocytic nevi remains one of the most challenging and controversial areas in
diagnostic histopathology. Although molecular diagnostic techniques have shown
some promise in differential diagnosis of melanoma, emergence of comparative
genomic hybridization that can screen entire genome for copy number changes
have become popular in distinguishing melanoma from nevi. Several studies
have revealed that most melanomas differ from nevi in their genetic makeup
(Bastian et al., 2003). These fundamental studies established the fact that
genetic factors/copy number can be valuable for histopathologically ambiguous
melanomas. In this aim, we use LDA and DSGA to build and test classification
models, compare the different techniques based on their classification
performance and identify the genes/copy number variations that distinguish the
two classes.
Method
Prior to classification, data was preprocessed to convert copy number data
to text. Different transformation approaches like ranking and threshold based
(methods section) were tested and the best performing technique. For ranking,
within each sample, genes were sorted in ascending order based on their copy
number values and the distribution is divided into 5 bins. Copy number
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segmentation threshold was also used to convert the copy number calls into
gain, normal and loss. Based on the segmented copy number data from copy
number inference pipeline, we customized the amplification and deletion
threshold for log2 ratios to >0.1 and < -0.3, respectively. When transforming the
copy number data to text, genes within the segments that contain log2 ratio
above 0.1 are labeled as G (gain) and the ones that have a log2 ratio of less than
-0.3 are labeled as L (loss), respectively. Any other value of log2 ratio is labeled
as N (normal).
LDA based classification approach was applied to copy number data from
skin cutaneous melanoma as discussed earlier and compare the performance
accuracies with other classifiers. For cross validation testing of the model, we
used 10-fold cross validation. Complete-linkage and Euclidean-distance based
hierarchical clustering was applied on the topic-sample matrix to cluster the
samples with similar probability distributions. Later, DSGA was applied to the raw
data resulting in a data matrix of 64 samples and 3300 genes. Dimension
reduction using W (k) shows a jump at k = 7 and this produced the 7-dimensional
HSM (Figure 24). Based on HSM, each tumor tissue is decomposed, and the
resulting disease component matrix is used for classification.
Data was visualized in mapper using the correlation metric. Copy number
data extracted from FFPE samples is expected to be extremely noisy and unlike
the gene expression data, is not dynamic in nature. Correlation metric normalizes
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the columns to become comparable and hence is used. Neighborhood 1&2 are
selected to project into a 2-dimensional space.
We used DAVID and GAD to identify differentially expressed genes that
associate with melanoma and nevi. Here, topic profiles from the datasets were
utilized to perform pathway analysis and disease annotation of differentially
expressed genes (DEGs) within each topic.

Figure 21 Topic probability distribution and Hierarchical clustering of
melanoma copy number data before DSGA.
Bar plots represent average topic-sample probability for the 3 topics. Heat map
shows the clustering of samples into two classes
Results
Comparing the topic probability distribution for both classes generated by
both approaches, threshold-based transformation performed significantly better
in terms of topic distribution and accuracy (Figure 21). For rank-based, the
separation in topics between melanoma and nevi was not significant. Better topic
distribution using copy number threshold can be attributed to the nature of the
data. Since the number of bins represents the relative ranking of copy number
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instead of absolute ranking, it was more suitable for gene expression data rather
than the discrete copy number data.

Figure 22 Topic probability distribution and Hierarchical clustering of
melanoma copy number data before DSGA.
Bar plots represent average topic-sample probability for the 3 topics. Heat map
shows the clustering of samples into two classes.

W (K)

Dimension of PC space = K

Figure 23 The wold invariant plot for melanoma copy number data
Graph plots goodness of fit measure W(k) versus the number of dimensions K to
determine correct dimension reduction for PCA.
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Comparison of the model performance using the cross validated model
accuracy indicate that while all the three models SVM, RF and LDA along with
DSGA were very highly accurate, RF+DSGA had the best performance albeit
only by a very small margin. The heat map in figures 22 and 23 shows that for
both analysis before and after DSGA, samples were grouped into two classes,
melanoma and nevi with good separation associated with the latter. Similarly,
comparing LDA performance before and after DSGA transformation, LDA after
transformation outperformed the other. Owing to the large number of variables
(24000) and small sample size (64), using LDA alone on the raw data did not
improve accuracy compared to other approaches. Visualization of the results
using mapper indicates that feature reduction using DSGA significantly improved
classification performance of LDA. DSGA transformation mostly separates the
malignant melanoma from the rest of the melanocytic nevi data.
Table 6 shows the top 5 highly related diseases which are ranked
ascendingly according to their p-value. As expected, for the gene list extracted
from copy number data corpus, ‘Melanoma’ is the disease with highest
enrichment (lowest p-value).
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Figure 24 Mapper output for melanoma copy number data before DSGA
The output displays melanoma samples (red bins). Each bin is colored by the
mean of the filter map on the points. Blue bins contain tumors whose total
deviation from HSM is small. Red bins contain tumors whose deviation from HSM
is large. White bins indicate the rest of the samples. Several bins (singletons)
are disconnected from the main graph.
Discussion
While both clustering results before and after DSGA (figures 22 and 23)
only partially separated samples between melanoma and nevi, the separation
was significant after DSGA. The very high accuracy achieved by all the three
models after DSGA transformation implies is due to the way, data were
transformed by DSGA. The high accuracy is also likely due to the relatively less
number of variables. Comparison of model performances using accuracy after
cross validation indicated the LDA+DSGA had the best performance. This
observation, in combination with the results of the other sub aims, further
validates the idea that a very high classification performance can be achieved
when DSGA precedes the standard classification approaches.
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Figure 25 Mapper output for melanoma copy number data after DSGA
The output displays melanoma samples (red bins). Each bin is colored by the
mean of the filter map on the points. Blue bins contain tumors whose total
deviation from HSM is small. Red bins contain tumors whose deviation from HSM
is large. White bins indicate the rest of the samples. Several bins (singletons)
are disconnected from the main graph.
Table 6 Classification results of DSGA transformed melanoma copy
number data using LDA, SVM, and Random Forest
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Although, with this dataset, SVM was only slightly behind LDA and RF
achieved little over in terms of classification performance. Even if we are
comparable with the state of art methods, we can be another contributor to the
ensemble methods.
An interesting observation to note is the visualization of the mapper plot
before and after transformation. While the earlier did show some separation
between the two sample groups, the latter separated melanoma entirely from the
rest of the cumulative dataset. Also, interesting to note is the fact that despite the
singletons in the mapper plot, clustering of melanoma samples after
transformation can be labeled as the tightest group in the plot. The difference is
likely because of the redundancy of the genes before and after transformation,
where the latter corresponds to only disease-relevant data deviating from the
nevi. It is important to indicate that the parameters used to visualize the two plots
are very similar as indicated above and hence justifying the comparison between
these two.
Some of the significant genes in the identified genomic regions from this
analysis are listed here: MCM10, CDKN2A, RAD51, IL9, CDK1, BCL2A1, IL13,
MAPK9, WNT2, CCL3 and myc. With regards to pathways associated with
variant genes between melanoma and nevi, calcium signaling, and olfactory
transduction being identified as the two top pathways is not surprising when
considering their functional role in driving melanoma. Regulation of intracellular
Ca2+ has an important impact on melanoma growth and metastasis. Significance
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of Olfactory transduction agrees with several reports that claim that most of the
cancer cell lines expressing olfactory receptors express the effectors necessary
for OR-mediated signal transduction. Another recent finding by Ranzani et al.,
(2017) confirmed the expression of OR2C3 gene that encodes olfactory receptor
2C3 protein, in human melanomas but not in normal melanocytes.

Table 7 Functional annotation of differentially
expressed genes in melanoma

Many of the enriched pathways are closely associated with tumorigenesis
and metastasis. In particular, the Wnt/ β-catenin pathway is associated with Wnt
signaling which regulates many genes implicated in melanoma. Deregulation of
the Wnt-related pathways reportedly affects melanoma proliferation and
differentiation (Jeff et al, 2013, Chien et al, 2009).
The application of DSGA for the first time to copy number data other than
gene expression data enabled the description of a robust copy number-based
melanoma/nevi classification. To confirm the pathological relevance of the
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extracted genes, we analyzed the functional correlation of the genes using
disease annotation and the diseases identified by the model are indeed
consistent with melanoma/skin cancer. The clear separation between beforeDSGA and after-DSGA samples in both analysis imply that the genes after the
feature reduction significantly played a role. Also, the fact that melanoma
samples clustered after-DSGA indicates that the genes after the feature
reduction closely associated with melanoma and hence melanoma is listed as
top1 disease.

Table 8 Functional annotation of differentially
expressed genes in melanoma
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Table 9 Top 5 related diseases from melanoma vs nevi
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V. SUMMARY AND CONCLUSION
The analysis of microarrays and next generation sequencing has become
one of the main research areas in computational biology, and new methods and
applications are continuously being developed. Here, we have reviewed
limitations of current statistical and machine learning methods and how Latent
Dirichlet Allocation could overcome these limitations.
Many approaches to diagnostic classification based on mRNA expression
focus primarily on differential expression. The LDA-based approach described
here differs in that the focus is primarily on co-expression. Just as textual LDA
attempts to group co-occurring words into topics to explain the topic composition
of a document, gene expression LDA can be used to identify co-regulated groups
of genes that together explain the overall patterns of gene expression in healthy
and disease states. In an unsupervised mode, this technique has shown a
somewhat surprising ability to produce gene-collections (topics) that differ
significantly between cancer and healthy tissues.

Specific aim conclusions
Specific aim 1
In both breast cancer and lung cancer gene expression data sets, LDA
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successfully classified tumor samples from normal with high accuracy and
identified relevant biological features/pathways. Some of the observations are
•

Ranking method was found to be effective compared to other methods for
converting gene expression data into text and vice-versa.

•

Choosing 3 topics, 10 iterations and 20 bins for LDA were determined
ideal for classification of tumor samples from normal samples based on
gene expression data in both breast cancer and lung cancer data.

•

LDA approach was proved to be effective compared to other state-of-art
machine learning classification methods in terms of classifying breast
cancer and lung cancer data from normal data.

•

LDA classification model was able to successfully identify known related
genes/pathways that contributed the most to differences in gene
expression profiling between tumor and normal samples.

Specific aim 2
In breast cancer gene expression data, a combination approach using LDA,
DSGA and TDA was successfully used to differentiate breast cancer subtypes
and identify relevant genes/pathways associated with specific subtypes. Some of
the observations include
•

LDA alone was not successful in classifying breast cancer subtypes based
on gene expression data. Significant difference was observed in LDA topic
separation after feature reduction using DSGA. LDA+DSGA performed the
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best compared to others in classifying multiple subtypes. When comparing
one-vs.-rest classes, LDA+DSGA still performed the best except for ER
and Luminal A, where, SVM+DSGA outperformed LDA although, all three
tested techniques resulted in very high accuracy. Further, topological
differences in gene expression from breast cancer subtype data before
and after DSGA-LDA resulted in separate clusters.
•

LDA-DSGA-TDA classification model was successfully applied to identify
known genes/pathways that contributed the most to differences between
breast cancer subtypes.

Specific aim 3
Highly accurate classification approach was constructed using LDA-DSGA-TDA
for classifying skin cutaneous melanoma from benign nevi based on copy
number data and the top distinctive chromosomal position/genes were identified.
Some of the observations are
•

Compared to rank-based, threshold-based approach was effective in
converting copy number data to text in terms of accuracy and
computational time.

•

Differences in copy number profiles of melanoma and nevi samples were
successfully modelled using LDA-DSGA-TDA approach. DSGA+RF
performed the best followed by DSGA+LDA and LDA alone performed the
worst, albeit, all tested techniques showed very high performance.
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•

Classification model based on the above approach using copy number
data from melanoma and nevi samples was successfully applied to
identify the known main drivers of the separation between these two
groups.
We believe that LDA is a promising method with numerous applications to

biomedical research. The above specific aims showed that LDA can accomplish
the task of clustering and classification of cancer genomic data. Furthermore,
each topic is interpreted as a probability distribution over words. That is,
compared with black-box algorithms, LDA can produce a more understandable
result and thus may help a biologist to interpret the finding. Meanwhile, unlike
traditional clustering, LDA allows data to come from a mixture of clusters rather
than from a single cluster. These characteristics may be useful in bioinformatics.
However, for hard-to-classify problems when LDA alone is not effective, we
identified that LDA+DSGA, a method that unravels the disease characteristics of
high dimensional genomic/proteomic data is effective. That is DSGA when
precedes standard class prediction techniques like SVM, RF or LDA enhances
their performance and ability to classify.
Overall our proposed pipeline provides a novel direction for applying the
LDA algorithm to identify and group differentially expressed genes between
healthy and cancer tissues of various types. A novel technique for transformation
of gene expression levels to words is presented and shown to be effective.
Comparative

evaluation

of

this

approach
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with

state-of-the-art

pattern

classification methods confirms the effectiveness of the proposed methodology.
Differential gene expression patterns associated with lung cancer, breast cancer,
breast cancer subtypes and melanoma were identified as relevant using pathway
analysis and the NIH’s genetic association database.
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VI. FUTURE DIRECTIONS
It has been demonstrated that the crucial factor in the application of LDA
to genomic data is the parameter selection like the number of topics. Choosing
the ideal number of topics is important for the overall distribution of words in LDA
that further affects the classification performance. One of the future directions
includes automating the selection of topics.
Other important issues that need to be addressed include testing and
validating the genes and pathways identified using our classification approach.
Our data showed that LDA-based functional analysis of cancer gene expression
data identified many relevant genes and pathways. Although these observations
suggest that LDA-based classification identified relevant genes differentiating the
different types of cancer, associating a validation metric can enhance the
significance of the study. Therefore, it will be worthy to further validate the
identified genes. This will be achieved by Precision @ k, a useful metric in text
mining that gives the fraction of relevant results out of the first k returned (for
example, P@10 or "Precision at 10" corresponds to the number of relevant
results on the first 10 returned). The same can be applied here by collecting N
known cancer related genes and at a cutoff k, calculating the precision of the N
known genes.

This gives us a validation of the gene subsets from our

classification.
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Lastly, other set of experiments that are worthy to carry out include
investigating other types of classifiers and build an ensemble classifier. Lots of best
classification approaches currently put together lots of different techniques and vote
(ensemble methods) (Sung et al, 2003, Hijazi et al, 2012, Nagi et al, 2013). These
experiments will therefore provide another voter, which is valuable because it gives
additional information to get better overall performance.
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